Ajax-Loading

Roche Holding AG - Capital Expenditures

Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.

The item "Capital-Expenditures" stands at 2.64 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value at least since 12/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -39.87 percent compared to the value the year prior.
The 1 year change in percent is -39.87.
The 3 year change in percent is -57.95.
The 5 year change in percent is -64.34.
The 10 year change in percent is -48.84.

The Serie's long term average value is 5.31 Billion Swiss Francs. It's latest available value, on 06/30/2025, is 50.22 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is +0.0%.
The Serie's change in percent from it's maximum value, on 03/31/2021, to it's latest available value, on 06/30/2025, is -68.98%.

Capital Expenditures for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Capital Expenditures905,699,262,464.00
LogoJohnson & Johnson - Capital Expenditures486,508,953,600.00
LogoAbbVie Inc - Capital Expenditures399,570,305,024.00
LogoAstraZeneca PLC - Capital Expenditures280,205,508,085.11
LogoNovartis AG - Capital Expenditures255,096,620,580.91